Canadian researchers published two major studies identifying a genetically distinct Ebola variant and proposing remdesivir as potential treatment option now in clinical trials. The rapid response leveraged four years of research infrastructure investment in viral modelling and genomic analysis tools originally developed during COVID-19 pandemic.
Dalhousie researchers identify new Ebola variant, propose repurposed drug treatment
The Ebola outbreak in Uganda and DRC prompted the WHO to declare a Public Health Emergency of International Concern, affecting populations in both countries.